RGEN logo

Repligen (RGEN) Company Overview

Profile

Full Name:

Repligen Corporation

Sector:

Healthcare

Country:

United States

IPO:

April 29, 1986

Indexes:

Not included

Description:

Repligen Corporation is a global biotechnology company that develops and commercializes highly innovative biotechnological technologies and systems to enhance the efficiency and flexibility of the production process of biological products. The company was founded in 1981 and is headquartered in Waltham, Massachusetts. The company's business is represented by a product line: Chromatography; Filtration; Process Analytics; Protein products; Other. Customers use the company's products for the production of drugs for clinical trials, then scale up to larger volumes as the drug transitions to commercial production after regulatory approval. Repligen Corporation's customers include biopharmaceutical companies, contract development organizations, and manufacturing organizations.

Key Details

Price

$158.99

Annual Revenue

$634.44 M(+0.33% YoY)

Annual EPS

-$0.46(-173.02% YoY)

Beta

1.21

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 20, 2025

Recent annual earnings:

Feb 20, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 21, 25 RBC Capital
Outperform
Feb 21, 25 JP Morgan
Overweight
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 21, 25 Canaccord Genuity
Hold
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 17, 24 Canaccord Genuity
Hold
Nov 14, 24 Wolfe Research
Peer Perform
Sep 26, 24 RBC Capital
Outperform
Aug 27, 24 Wells Fargo
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Repligen?
  • Does Repligen pay dividends?
  • What sector is Repligen in?
  • What industry is Repligen in?
  • What country is Repligen based in?
  • When did Repligen go public?
  • Is Repligen in the S&P 500?
  • Is Repligen in the NASDAQ 100?
  • Is Repligen in the Dow Jones?
  • When was Repligen's last earnings report?
  • When does Repligen report earnings?
  • Should I buy Repligen stock now?

What is the ticker symbol for Repligen?

The ticker symbol for Repligen is NASDAQ:RGEN

Does Repligen pay dividends?

No, Repligen does not pay dividends

What sector is Repligen in?

Repligen is in the Healthcare sector

What industry is Repligen in?

Repligen is in the Medical Instruments & Supplies industry

What country is Repligen based in?

Repligen is headquartered in United States

When did Repligen go public?

Repligen's initial public offering (IPO) was on April 29, 1986

Is Repligen in the S&P 500?

No, Repligen is not included in the S&P 500 index

Is Repligen in the NASDAQ 100?

No, Repligen is not included in the NASDAQ 100 index

Is Repligen in the Dow Jones?

No, Repligen is not included in the Dow Jones index

When was Repligen's last earnings report?

Repligen's most recent earnings report was on Feb 20, 2025

When does Repligen report earnings?

The next expected earnings date for Repligen is May 1, 2025

Should I buy Repligen stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions